Bioactivity:

Grazoprevir is a drug approved for the treatment of hepatitis C. Grazoprevir is a second-generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets.

CAS nr:

1206524-86-8

Purity:

98%

Molecular Weight:

805

SMILES:

COC1=CC2=NC3=C(CCCCC[C@@H]4C[C@H]4OC(N[C@@H](C(C)(C)C)C(N5C[C@H](O3)C[C@H]5C(N[C@]6(C([N-]S(=O)(C7CC7)=O)=O)C[C@H]6C=C)=O)=O)=O)N=C2C=C1.[K+]

Formula:

C38H49KN6O9S

Pathway:

Target: